Elisa Stefanini

Her experience includes clinical trials, market access, promotion and distribution of medicinal products, including biosimilars and ATMPs, and medical devices. She has also accrued a significant experience in digitalization projects, including Patient Support Programs (PSP) and e-commerce/home delivery projects undertaken by pharmacies as well as with respect to the development of telemedicine services, software as medical devices and the use of artificial intelligence in the healthcare sector.

Elisa is ranked by Chambers Europe 2025 for Life Sciences (Band 2), by The Legal 500 EMEA 2025 as “Leading partner” for Life Sciences and Healthcare, and by Lexology Index (formerly Who’s Who Legal) as “Thought Leaders” in Healthcare & Life Sciences 2025 (Regulatory).

During her PhD, she authored several academic publications in the field of biotechnology and scientific research, including the monograph “Genetic Data and Fundamental Rights. Comparative and European Law” (CEDAM, 2008), and she regularly contributes to newsletters and journals on regulatory Life Sciences topics. She is regularly speakers in seminars and training events, including those organized by IQVIA, on Life Sciences topics.

Elisa graduated cum laude Law Degree from Università Commerciale Luigi Bocconi in Milan in 2004; she earned a post-graduate diploma at the Academy of European Law, European University Institute in Florence in 2006 and completed her Ph.D. in Constitutional Law at the Università degli Studi di Milano in 2008. During her doctoral studies, Elisa conducted research at the King’s College London. From 2006 to 2010, she was Contract Professor in Public and Constitutional Law at the Università Commerciale Luigi Bocconi.

She is officer in the Healthcare and Life Sciences Law Committee of the International Bar Association (IBA) and Vice-President of the Healthcare and Life Sciences Commission of the International Association of Young Lawyers (AIJA).